D. Dörffel et al.: J Extra Corpor Technol 2025, 57, 89 – 95 95
Ethics approval
This study protocol was reviewed and approved by the Ethics Committee of the Charité – Universitätsmedizin Berlin( approval reference EA2 / 096 / 23).
The written consent of the patients was not required, as this was an anonymous evaluation of the quality control of the automated autotransfusion by means of a retrospective data analysis, as agreed with the ethics committee of Charité – Universitätsmedizin Berlin.
References
1. Müller M, Geisen C, Zacharowski K, Tonn T, Seifried E. Transfusion of packed red cells: indications, triggers and adverse events. Dtsch Arztebl Int. 2015; 112:507 – 518.
2. Eichler H, Feyer AK, Weitmann K, et al. Population-based analysis of the impact of demographics on the current and future blood supply in the saarland. Transfus Med Hemother. 2021; 48( 3): 175 – 182.
3. Schönborn L, Weitmann K, Greger N, Kiefel V, Hoffmann W, Greinacher A. Longitudinal changes in the blood supply and demand in North-East-Germany 2005 – 2015, Transfus Med Hemother. 2017; 44( 4): 224 – 231.
4. Greinacher A, Fendrich K, Brzenska R, Kiefel V, Hoffmann W. Implications of demographics on future blood supply: a populationbased cross-sectional study. Transfusion. 2011; 51( 4): 702 – 709.
5. WHO. Sixty-third world health assembly, WHA 63.12, Agenda item 11.17, Availability, safety and quality of blood products. 2010. Available at: https:// www. who. int / publications / i / item / WHA63.12. Accessed November 14, 2024.
6. SABM. Society for the advancement of blood management, administrative and clinical standards for patient blood management programs, 5th edn, 2019. Available at: https:// www. sabm. org / assets / aware / SABM % 20Standards % 202019. pdf Accessed November 14, 2024.
7. WHO. Global status report on blood safety and availability 2021. 2022. Available at: https:// www. who. int / publications / i / item / 9789240051683. Accessed November 14, 2024.
8. Bolton-Maggs PHB. Conference report: International Haemovigilance Seminar and the SHOT Annual Symposium, 10 – 12 July 2018. Transfus Med. 2019; 29( 4): 247 – 252.
9. Kulhas Celik I, Koca Yozgat A, Dibek Misirlioglu E, et al. Frequency and clinical characteristics of allergic transfusion reactions in children. Transfus Apher Sci. 2021; 60( 4): 103152.
10. Hayat H, Ahmed Q, Alam H, Rashid A. Non-severe allergic transfusion reaction: a hidden cause of wastage of blood product and laboratory resources. Vox Sang. 2023; 118( 3): 193 – 198.
11. Bundesärztekammer. Richtlinie zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten( Richtlinie Hämotherapie), Gesamtnovelle 2023. 2023. Available at: https:// www. bundesaerztekammer. de / fileadmin / user _ upload / BAEK / Themen / Medizin _ und _ Ethik / Richtlinie-Haemotherapie- 2023 _ neu2. pdf. Accessed November 14, 2024.
12. Tachias F, Samara E, Petrou A, et al. The effect of cell salvage on bleeding and transfusion needs in cardiac surgery. Anesthesiol Res Pract. 2022; 2022:3993452.
13. Alberts M, Groom RC, Walczak R, et al. In vitro evaluation of the Fresenius Kabi CATSmart autotransfusion system. J Extra Corpor Technol. 2017; 49( 2): 107 – 111.
14. Melchior RW, Dreher M, Shade B, Chappell A, Fisher D, Rosenthal T. Comparison of three autotransfusion devices for utilization in the pediatric population. Perfusion. 2021; 36( 1): 57 – 62.
15. Seyfried TF, Gruber M, Streithoff F, et al. The impact of bowl size, program setup, and blood hematocrit on the performance of a discontinuous autotransfusion system. Transfusion. 2017; 57( 3): 589 – 598.
16. Luque-Oliveros M. Haematological alterations in the cardiac patient after use of an autotransfusion system. Rev Esp Anestesiol Reanim( Engl Ed). 2018; 65( 2): 74 – 80.
17. HanZ, WangM, YuS. Effectsofstoredautotransfusionon electrolytes and postoperative complications in patients undergoing elective orthopedic surgery. Am J Transl Res. 2021; 13( 6): 7200 – 7206.
18. LivaNova. Xtra Ò – The eXtraordinary flexible, intuitive and powerful Autotransfusion System( ATS). 2022. Available at: https:// www. livanova. com / cardiopulmonary / getmedia / b5a44a99- fce1-4390-8656-388495f14c18 / xtrabrochure _ ous. pdf. Lastaccess 07 / 22 / 2023. Accessed November 14, 2024.
19. Yarham G, Clements A, OliverM, et al. Evaluating the“ next generation” of cell salvage – will it make a difference? Perfusion. 2011; 26( 4); 263 – 270.
20. Overdevest EP, Lanen PW, Feron JC, van Hees JW, Tan ME. Clinical evaluation of the Sorin Xtra( R) Autotransfusion System. Perfusion. 2012; 27( 4): 278 – 283.
21. Stasko AJ, Stammers AH, Mongero LB, Tesdahl EA, Weinstein S. The influence of intraoperative autotransfusion on postoperative hematocrit after cardiac surgery: a cross-sectional study. J Extra Corpor Technol. 2017; 49( 4): 241 – 248.
22. Baumann C, Lamesic G, Weiss M, Cushing MM, Haas T. Evaluation of the minimum volume of salvage blood required for the successful use of two different autotransfusion devices. Paediatr Anaesth. 2015; 25( 3): 258 – 264.
Cite this article as: Dörffel D, Klotz E, Wagner P, Ehrig K, Pretzel K, Hanisch F & Pruß A. Hematocrit and total protein elimination as quality control parameters of cell salvagesalvage. J Extra Corpor Technol 2025, 57, 89 – 95. https:// doi. org / 10.1051 / ject / 2025013.